Hai-Wei Zhang

A dual-glycoprotein-targeting bispecific nanoantibody confers potent neutralization against Nipah virus.

Nipah virus (NiV) is a biosafety level 4 pathogen that has consistently posed a significant threat to public health. The two envelope proteins on the viral surface, the receptor-binding protein (RBP) and the fusion (F) protein, are the primary targets of neutralizing antibodies. However, the use of antibodies targeting...